PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
PetDx has raised $62.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
PetDx's investors include Valor Equity Partners, Torch Capital, Declaration Partners, LabCorp, Petco.
PetDx is headquartered in La Jolla, United States.
PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
PetDx is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PetDx — Funding & Investors." VCBacked, December 9, 2021, https://www.vcbacked.co/company/petdx. Accessed September 30, 2026.
VCBacked. (2021). PetDx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/petdx
{{cite web |title=PetDx — Funding & Investors |url=https://www.vcbacked.co/company/petdx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated